To view this email as a web page, click here.
Conference Coverage
 
 September 17, 2018
 
EADV 2018 is taking place this week in Paris. Here’s the latest from the meeting. Visit our conference page for more news from the meeting.
 
Life-threatening emergency cases in dermatology
Life-threatening emergency cases may be rare, but they can be complex. At EADV this week, experts review cases physicians should be aware of.
 
Dupilumab may be for adolescents too, EADV report shows
A study presented at EADV in Paris today showed that dupilumab met its primary endpoints in a phase three study of adolescents with moderate-to-severe atopic dermatitis.
 
JAK trial effectively reverses alopecia areata
EADV report shows that two JAK inhibitors reverses alopecia areata in some patients.
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.